Suppr超能文献

转化生长因子β在促结缔组织增生性成釉细胞瘤中的免疫表达

Immunoexpression of transforming growth factor beta in desmoplastic ameloblastoma.

作者信息

Takata T, Miyauchi M, Ogawa I, Kudo Y, Takekoshi T, Zhao M, Sato S, Nikai H, Komiyama K

机构信息

Department of Oral Pathology, Hiroshima University School of Dentistry, Japan.

出版信息

Virchows Arch. 2000 Apr;436(4):319-23. doi: 10.1007/s004280050453.

Abstract

Desmoplastic ameloblastoma (DA) is an unusual subtype of ameloblastoma histologically characterized by the pronounced collagenized stroma. In the present study, the immunolocalization of transforming growth factor beta (TGF-beta), one of the most potent local factors for modulating extracellular matrix formation, was observed in DA in order to study its participation in the stromal desmoplasia. Seven cases of DA, including a "hybrid" lesion, were studied together with ten cases of ordinary follicular and plexiform ameloblastomas as the control. In contrast to ordinary ameloblastomas, marked immunoexpression was observed in all DAs but one. In the "hybrid" lesion, TGF-beta was not expressed in the area of follicular ameloblastoma but in that of DA. These results show that TGF-beta produced by tumor cells of DA plays a part in the desmoplastic matrix formation.

摘要

促结缔组织增生性成釉细胞瘤(DA)是成釉细胞瘤的一种特殊亚型,其组织学特征为显著的胶原化间质。在本研究中,为了研究转化生长因子β(TGF-β)参与基质形成的情况,观察了其在促结缔组织增生性成釉细胞瘤中的免疫定位,TGF-β是调节细胞外基质形成的最有效局部因子之一。研究了7例促结缔组织增生性成釉细胞瘤,包括1例“混合性”病变,同时以10例普通滤泡型和丛状成釉细胞瘤作为对照。与普通成釉细胞瘤不同,除1例之外,所有促结缔组织增生性成釉细胞瘤均观察到明显的免疫表达。在“混合性”病变中,TGF-β在滤泡型成釉细胞瘤区域未表达,但在促结缔组织增生性成釉细胞瘤区域表达。这些结果表明,促结缔组织增生性成釉细胞瘤肿瘤细胞产生的TGF-β在促结缔组织基质形成中起作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验